Telesis Bio, Inc. (TBIO)
NASDAQ: TBIO · Real-Time Price · USD
1.360
-0.040 (-2.86%)
At close: Sep 18, 2024, 4:00 PM
1.610
+0.250 (18.38%)
After-hours: Sep 18, 2024, 6:51 PM EDT

Telesis Bio Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Revenue
19.5727.5127.4411.046.585.77
Revenue Growth (YoY)
-29.68%0.27%148.44%67.93%14.05%-
Cost of Revenue
10.0610.5611.846.742.953.21
Gross Profit
9.5116.9515.64.33.632.55
Selling, General & Admin
31.0834.638.6224.9111.066.94
Research & Development
13.9117.523.4614.478.933.98
Operating Expenses
44.9952.162.0839.3719.9910.92
Operating Income
-35.48-35.15-46.49-35.07-16.36-8.37
Interest Expense
-2.19-3.11-1.96-1.37-0.69-1.79
Interest & Investment Income
1.371.740.74---
Other Non Operating Income (Expenses)
0.190.34-0.02-1.56-0.880.43
EBT Excluding Unusual Items
-36.11-36.18-47.72-38-17.93-9.73
Merger & Restructuring Charges
----0.3--
Impairment of Goodwill
-11.39-11.39----
Gain (Loss) on Sale of Assets
-0.26-0.14-0-0.03--0.23
Asset Writedown
-1.02----0.07-
Other Unusual Items
---0.73-0.62--
Pretax Income
-48.78-47.7-48.45-38.94-18.01-9.96
Income Tax Expense
0.020.020.020.010.01-
Net Income
-49.54-47.72-48.47-38.96-18.01-9.96
Preferred Dividends & Other Adjustments
2.331.3----
Net Income to Common
-51.87-49.02-48.47-38.96-18.01-9.96
Shares Outstanding (Basic)
222100
Shares Outstanding (Diluted)
222100
Shares Change (YoY)
2.24%1.31%61.69%264.34%0.03%-
EPS (Basic)
-30.82-29.56-29.61-38.48-64.82-35.86
EPS (Diluted)
-30.82-29.56-29.61-38.48-64.82-35.86
Free Cash Flow
-22.79-36.65-43.18-38.55-15.59-7.76
Free Cash Flow Per Share
-13.54-22.10-26.38-38.08-56.09-27.95
Gross Margin
48.60%61.62%56.84%38.93%55.12%44.29%
Operating Margin
-181.35%-127.78%-169.44%-317.61%-248.80%-145.18%
Profit Margin
-265.09%-178.21%-176.68%-352.78%-273.87%-172.78%
Free Cash Flow Margin
-116.50%-133.22%-157.40%-349.11%-237.00%-134.63%
EBITDA
-32.89-32.83-44.81-34.17-15.5-7.34
EBITDA Margin
-168.09%-119.34%-163.35%--235.63%-127.35%
D&A For EBITDA
2.62.321.670.910.871.03
EBIT
-35.48-35.15-46.49-35.07-16.36-8.37
EBIT Margin
-181.35%-127.78%-169.44%--248.80%-145.18%
Revenue as Reported
19.5727.5127.4411.046.585.77
Advertising Expenses
-0.710.90.8-
Source: S&P Capital IQ. Standard template. Financial Sources.